Peter C. M. McWilliams
Chief Executive Officer at Actimis Pharmaceuticals, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gilbert N. Miller | M | - |
Artielle ImmunoTherapeutics, Inc.
 Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 23 years |
| Timothy J. Wollaeger | M | 80 |
Harkness Pharmaceuticals, Inc.
 Harkness Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Harkness Pharmaceuticals, Inc. develops novel therapies for obesity. The firm offers human clinical trials for its first product, an oral formulation of the peptide enterostatin for the treatment of obesity. The company was founded by Edward Dennis and Byron Rubin in 2003 and is headquartered in San Diego, CA.
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | 30 years |
| Michael Dixon | M | - |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California.
Liphorus Pharmaceuticals, Inc.
 Liphorus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Liphorus Pharmaceuticals, Inc. develops small molecules effective in treating high cholesterol. The company was founded in 2014 and is headquartered in Montréal, Canada. | 11 years |
| Byron Rubin | M | - |
Harkness Pharmaceuticals, Inc.
Harkness Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Harkness Pharmaceuticals, Inc. develops novel therapies for obesity. The firm offers human clinical trials for its first product, an oral formulation of the peptide enterostatin for the treatment of obesity. The company was founded by Edward Dennis and Byron Rubin in 2003 and is headquartered in San Diego, CA. | 21 years |
| Arthur A. Vandenbark | M | - |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
| Halina Offner | M | - |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
| Paulette Taylor | F | - |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | 28 years |
| Edward A. Dennis | M | 82 |
Harkness Pharmaceuticals, Inc.
Harkness Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Harkness Pharmaceuticals, Inc. develops novel therapies for obesity. The firm offers human clinical trials for its first product, an oral formulation of the peptide enterostatin for the treatment of obesity. The company was founded by Edward Dennis and Byron Rubin in 2003 and is headquartered in San Diego, CA. | 21 years |
| Brock Metcalf | M | - |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | - |
| Mike Diem | M | 54 |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | - |
| Andrew Jennings | M | - |
Liphorus Pharmaceuticals, Inc.
Liphorus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Liphorus Pharmaceuticals, Inc. develops small molecules effective in treating high cholesterol. The company was founded in 2014 and is headquartered in Montréal, Canada. | 10 years |
| Christopher Starr | M | 71 |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | 8 years |
| Fred Middleton | M | 74 |
Actimis Pharmaceuticals, Inc.
 Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA.
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | 37 years |
| Robert McNeil | M | 81 |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | 45 years |
| Harold T. Shapiro | M | 89 |
Princeton University
| 36 years |
| Steven Jon Axon | M | 49 |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | - |
| Nancy Hardwick | F | - |
Booz Allen Hamilton, Inc.
 Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | 28 years |
| Pierre Beauparlant | M | - |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | 7 years |
| Niall O'Donnell | M | 51 |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | - |
| Steve Pollitt | M | - |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | 16 years |
| Ken Harrison | M | - |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | - |
| René Castro | M | - |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | 15 years |
| Kenneth Harrison | M | 44 |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | - |
| Laurie Hodrick | M | 60 |
Columbia Business School
| 28 years |
| Shahab Fatheazam | M | 72 |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
| René Kuijten | M | 60 |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | - |
| Gail Maderis | F | 66 |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | - |
| Taro Inaba | M | 56 |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA. | - |
| S. Torres | M | 61 |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | - |
| Timothy C. Mills | M | 68 |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | 24 years |
| Burt Malkiel | M | 90 |
Princeton University
| 36 years |
| Benjamin McGraw | M | 75 |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | - |
| Philip L. Smith | M | 74 |
Trinity Biosystems, Inc.
Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Trinity Biosystems, Inc. develops and formulates orally delivered bio-therapeutic macromolecules. It offers TriPex system, an approach to macromolecule delivery that works cooperatively with the natural physiology of the body. The system utilizes a specific and natural biological transport mechanism: a receptor-mediated transcellular transport pathway that allows passage through the mucosal epithelium and delivery of the therapeutic payload into the blood. The company was founded by Randall J. Mrsny on July 19, 2002 and is headquartered in Menlo Park, CA. | - |
| Jim Trenkle | M | - |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Samuel R. Strickland | M | 73 |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | 18 years |
| Robert A. Swanson | M | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Luca Anderlini | M | 66 |
University of Cambridge
| 17 years |
| Kevin Chan | M | - |
Columbia Business School
University of Cambridge
| 6 years |
| Nicholas Taylor | M | 55 |
University of Cambridge
| 5 years |
| Michael John Wilson | M | - |
University of Cambridge
| 8 years |
| Chi Keung Lau | M | 69 |
University of Cambridge
| 5 years |
| Jonathan Mark Huntley | M | - |
University of Cambridge
| 8 years |
| Stephen Spencer Kotsen | M | - |
Columbia Business School
Princeton University
| 7 years |
| Sheila Harilal Patel | F | - |
Columbia Business School
Princeton University
| 7 years |
| Teck Huat Tan | M | 63 |
University of Cambridge
| 4 years |
| Pedro Urquidi | M | 53 |
Columbia Business School
Princeton University
| 7 years |
| Steven Lo | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| John Simon Hunt | M | 61 |
University of Cambridge
| 4 years |
| Vishva Dixit | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| George Bumeder | M | 54 |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA.
Princeton University
| 9 years |
| Bojosi Otlhogile | M | - |
University of Cambridge
| 7 years |
| Paula Disberry | F | 56 |
University of Cambridge
| 5 years |
| Robert D. Stock | M | - |
Princeton University
| 4 years |
| Ingrid Boyes | F | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 years |
| Kevin A. Davis | M | - |
Princeton University
| 4 years |
| Trevor Thomas | M | - |
University of Cambridge
| 7 years |
| Mark Maybury | M | - |
University of Cambridge
| 5 years |
| Wing Hoy Tsang | M | 55 |
University of Cambridge
| 8 years |
| Yannis A. Koskosidis | M | - |
Princeton University
| 4 years |
| Ka-Pik So | F | - |
University of Cambridge
| 4 years |
| Matt Drapkin | M | 50 |
Princeton University
Columbia Business School
| 7 years |
| Andy P. Maunder | M | - |
Oxford Molecular Group Plc
| - |
| Marc Conner | M | - |
Princeton University
| 4 years |
| Oliver Boucher | M | - |
University of Cambridge
| 6 years |
| Erik Blachford | M | 56 |
Princeton University
Columbia Business School
| 7 years |
| R. Michael McCullough | M | 85 |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | 31 years |
| Martin Roper | M | 61 |
University of Cambridge
| 5 years |
| Julian Healy | M | 62 |
University of Cambridge
| 5 years |
| Peter Rathjens | M | 65 |
Princeton University
| 4 years |
| Ram shenoy | M | - |
University of Cambridge
| 3 years |
| Gabrielle Walker | M | - |
University of Cambridge
| 7 years |
| Marianne T. Armstrong | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 3 years |
| Mike Webster | M | - |
University of Cambridge
| 5 years |
| Christopher A. Grew | M | - |
University of Cambridge
| 6 years |
| Wing Yan Lo | M | 63 |
University of Cambridge
| 3 years |
| Roy Merritt | M | 60 |
University of Cambridge
| 4 years |
| Gilberto Arias | M | - |
University of Cambridge
| 4 years |
| Hugh Anthony Simons | M | - |
University of Cambridge
| 3 years |
| Sarah Hymowitz | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 22 years |
| Wendy Young | M | - |
Princeton University
| 4 years |
| Jonathan Aberman | M | - |
University of Cambridge
| 8 years |
| Tom Muscarella | M | - |
Sanderling Management CO LLC
Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | - |
| Cesare Zetti | M | 57 |
University of Cambridge
| 3 years |
| Ting Min Tan | F | 55 |
University of Cambridge
| 7 years |
| R. Dominic King-Smith | M | - |
University of Cambridge
| 7 years |
| Vassilios Niko Nicopoulos | M | - |
Princeton University
| 5 years |
| Richard V. Penty | M | - |
University of Cambridge
| 8 years |
| Tin Chee Ip | M | 62 |
University of Cambridge
| 6 years |
| Alastair K. Livesey | M | 67 |
University of Cambridge
| 3 years |
| David Bros | M | - |
Princeton University
| 4 years |
| Jason Kamras | M | - |
Princeton University
| 4 years |
| Jonathan Huberman | M | 58 |
Princeton University
| 4 years |
| Ken J. Ruskin | M | - |
Princeton University
| 4 years |
| Stewart L. McDowell | F | - |
Princeton University
| 4 years |
| Rick J. Corcoran | M | - |
Princeton University
| 4 years |
| Matthew Blumberg | M | 53 |
Princeton University
| 4 years |
| William T. Burke | M | - |
Princeton University
| 4 years |
| Yasha Gofman | M | - |
Princeton University
| 4 years |
| Andrew Hayden O'Brien | M | - |
Princeton University
| 4 years |
| James Smith | M | - |
Princeton University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 67 | 67.00% |
| United Kingdom | 33 | 33.00% |
| Canada | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter C. M. McWilliams
- Personal Network
